Glucocorticoid receptor polymorphisms in major depression

Annals of the New York Academy of Sciences

Volumn 1179, Issue , 2009, Pages 216-228

  Claes, Stephan ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Glucocorticoid receptor; Glucocorticoid receptor gene; HPA axis; Major depressive disorder

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DEXAMETHASONE; FK 506 BINDING PROTEIN; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; IMIPRAMINE;

BEHAVIOR CHANGE; CONFERENCE PAPER; DEPRESSION; GENE MUTATION; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HAPLOTYPE; HIPPOCAMPUS; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; NONHUMAN; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS; TRANSGENIC ANIMAL;

ANIMALIA;

DEPRESSIVE DISORDER, MAJOR; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; POLYMORPHISM, GENETIC; RECEPTORS, GLUCOCORTICOID;

EID: 70449334130     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05012.x     Document Type: Conference Paper

References (70)

1. Sullivan, P.F., M.C. Neale & K.S. Kendler. 2000. Genetic epidemiology of major depression: review and meta-analysis. Am. J. Psychiatry 157: 1552-1562.
2. Kendler, K.S. et al. 2006. A Swedish national twin study of lifetime major depression. Am. J. Psychiatry 163: 109-114.
3. Hettema, J.M. et al. 2006. A population-based twin study of the relationship between neuroticism and internalizing disorders. Am. J. Psychiatry 163: 857-864.
4. Mazure, C.M. et al. 2000. Adverse life events and cognitive-personality characteristics in the prediction of major depression and antidepressant response. Am. J. Psychiatry 157: 896-903.
5. Kendler, K.S. et al. 2003. Life event dimensions of loss, humiliation, entrapment, and danger in the prediction of onsets of major depression and generalized anxiety. Arch. Gen. Psychiatry 60: 789-796.
6. Duncan, R. D. et al. 1996. Childhood physical assault as a risk factor for PTSD, depression, and substance abuse: findings from a national survey. Am. J. Orthopsychiatry 66: 437-448.
7. Mullen, P. E. et al. 1988. Impact of sexual and physical abuse on women's mental health. Lancet 1: 841-845.
8. Sachar,E. J.,D.K. Fukushima&T.F. Gallagher. 1970. Cortisol production in depressive illness. A clinical and biochemical clarification. Arch. Gen. Psychiatry 23: 289-298.
9. Gold, P.W.,W.C.Drevets&D.S.Charney. 2002. New insights into the role of cortisol and the glucocorticoid receptor in severe depression. Biol. Psychiatry 52: 381-385.
10. Nemeroff, C.B. et al. 1988. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch. Gen. Psychiatry 45: 577-579.
11. Austin,M.C., J.E. Janosky & H.A. Murphy. 2003. Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men. Mol. Psychiatry 8: 324-332.
12. Bissette, G. et al. 2003. Elevated concentrations of CRF in the locus coeruleus of depressed subjects. Neuropsychopharmacology 28: 1328-1335.
13. Merali, Z. et al. 2005. Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects. Biol. Psychiatry 59: 594-602.
14. Raadsheer, F.C. et al. 1994. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60: 436-444.
15. Holsboer-Trachsler, E., R. Stohler & M. Hatzinger. 1991. Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression. Psychiatry Res. 38: 163-171.
16. Holsboer, F. 2000. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23: 477-501.
17. Ribeiro S.C. et al. 1993. The DST as a predictor of outcome in depression: a meta-analysis. Am. J. Psychiatry 150: 1618-1629.
18. Heim, C. et al. 2000. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 284: 592-597.
19. Heim, C. et al. 2008. The dexamethasone/ corticotropin-releasing factor test in men with major depression: role of childhood trauma. Biol. Psychiatry 63: 398-405.
20. Tyrka, A.R. et al. 2008. Childhood parental loss and adult hypothalamic-pituitary-adrenal function. Biol. Psychiatry 63: 1147-1154.
21. Bartels, M. et al. 2003. Heritability of cortisol levels: review and simultaneous analysis of twin studies. Psychoneuroendocrinology 28: 121-137.
22. Federenko, I.S. et al. 2004. The heritability of hypothalamus pituitary adrenal axis responses to psychosocial stress is context dependent. J. Clin. Endocrinol. Metab. 89: 6244-6250.
23. Federenko, I.S. et al. 2006. The heritability of perceived stress. Psychol. Med. 36: 375-385.
24. Holsboer, F., et al. 1995. Altered hypothalamicpituitary- adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 62: 340-347.
25. Refojo, D. & F. Holsboer. 2009. CRH signaling: molecular specificity for drug targeting in the central nervous system. Ann. N. Y. Acad. Sci. Glucocorticoids and Mood: Clinical Manifestations, Risk Factors, and Molecular Mechanisms. In press.
26. Modell, S. et al. 1998. Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders. Neuropsychopharmacology 18: 253-262. (Pubitemid 28085524)
27. Swanson, L.W., &D.M. Simmons. 1989. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the rat. J. Comp. Neurol. 285: 413-435.
28. Herman, J. P. et al. 1989. Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis. J. Neurosci. 9: 3072-3082.
29. Pariante, C.M. et al. 2004. Four days of citalopram increase suppression of cortisol secretion by prednisolone in healthy volunteers. Psychopharmacology (Berl.) 177: 200-206.
30. Mason, B.L. & C.M. Pariante. 2006. The effects of antidepressants on the hypothalamic- pituitary-adrenal axis. Drug News Perspect. 19: 603-608.
31. Carvalho, L.A. et al. 2008. Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not in patients with major depression. Neuropsychopharmacology 33: 3182-3189.
32. Pariante, C.M. 2004. Glucocorticoid receptor function in vitro in patients with major depression. Stress 7: 209-219.
33. Ladd, C.O. et al. 2004. Long-termadaptations in glucocorticoid receptor and mineralocorticoid receptor mRNA and negative feedback on the hypothalamopituitary- adrenal axis following neonatal maternal separation. Biol. Psychiatry 55: 367-375.
34. Weaver, I.C. et al. 2004. Epigenetic programming by maternal behavior. Nat. Neurosci. 7: 847-854.
35. Reichardt, H.M. et al. 1998. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93: 531-541.
36. Ridder, S. et al. 2005. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J. Neurosci. 25: 6243-6250.
37. Boyle, M.P. et al. 2005. Acquired deficit of forebrain glucocorticoid receptor produces depressionlike changes in adrenal axis regulation and behavior. Proc. Natl. Acad. Sci. USA 102: 473-478.
38. Binder, E.B. et al. 2004. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat. Genet. 36: 1319-1325.
39. Binder, E.B. et al. 2008. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 299: 1291-1305.
40. De Rijk, R.H. & E.R. De Kloet. 2008. Corticosteroid receptor polymorphisms: determinants of vulnerability and resilience. Eur. J. Pharmacol. 583: 303-311.
41. Russcher, H. et al. 2007. Associations between promoter usage and alternative splicing of the glucocorticoid receptor gene. J. Mol. Endocrinol. 38: 91-98.
42. Kumar, R.&E.B.Thompson. 2005. Gene regulation by the glucocorticoid receptor: structure:function relationship. J. Steroid. Biochem. Mol. Biol. 94: 383-394.
43. De Rijk, R.H., M. Schaaf & E.R. De Kloet. 2002. Glucocorticoid receptor variants: clinical implications. J. Steroid. Biochem. Mol. Biol. 81: 103-122.
44. Russcher, H. et al. 2005. Increased expression of the glucocorticoid receptor-A translational isoform as a result of the ER22/23EK polymorphism. Mol. Endocrinol. 19: 1687-1696.
45. van Rossum, E.F. & S.W. Lamberts. 2004. Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog. Horm. Res. 59: 333-357.
46. Koeijvoets, K.C. et al. 2006. Functional polymorphism in the glucocorticoid receptor gene and its relation to cardiovascular disease risk in familial hypercholesterolemia. J. Clin. Endocrinol. Metab. 91: 4131-4136.
47. Van Rossum, E.F. et al. 2002. A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes 51: 3128-3134.
48. Kumsta, R. et al. 2007. Sex specific associations between common glucocorticoid receptor gene variants and hypothalamus-pituitary-adrenal axis responses to psychosocial stress. Biol. Psychiatr. 62: 863-869.
49. Russcher, H. et al. 2005. Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression. J. Clin. Endocrinol. Metab. 90: 5804-5810.
50. Dobson, M.G. et al. 2001. The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetesmellitus. J. Clin. Endocrinol. Metab. 86: 2270-2274.
51. Jewell, C.M. & J.A. Cidlowski. 2007. Molecular evidence for a link between the N363S glucocorticoid receptor polymorphism and altered gene expression. J. Clin. Endocrinol. Metab. 92: 3268-3277.
52. Wust, S. et al. 2004. Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. J. Clin. Endocrinol. Metab. 89: 565-573.
53. Weaver, J.U., G.A. Hitman & P.G. Kopelman. 1992. An association between a Bc1I restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women. J. Mol. Endocrinol. 9: 295-300.
54. Buemann, B. et al. 1997. Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obes. Res. 5: 186-192.
55. Rosmond, R. et al. 2000. A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamicpituitary- adrenal axis. Obes. Res. 8: 211-218.
56. Derijk, R.H. et al. 2001. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis. J. Rheumatol. 28: 2383-2388.
57. Donn, R., D. Payne & D. Ray. 2007. Glucocorticoid receptor gene polymorphisms and susceptibility to rheumatoid arthritis. Clin. Endocrinol. (Oxf.) 67: 342-345.
58. Syed, A.A. et al. 2006. Association of glucocorticoid receptor polymorphism A3669G in exon 9beta with reduced central adiposity in women. Obesity (Silver Spring) 14: 759-764.
59. Van West, D. et al. 2006. Glucocorticoid receptor gene-based SNP analysis in patients with recurrent major depression. Neuropsychopharmacology 31: 620-627.
60. Wust, S. 2007. Presentation at the Second Meeting of West European Societies of Biological Psychiatry, 13-15 December 2007, Strasbourg, France.
61. Derijk,R.H. et al. 2008. Corticosteroid receptor-gene variants: modulators of the stress-response and implications for mental health. Eur. J. Pharmacol. 585: 492-501.
62. Feng, J. et al. 2000. Five missense variants in the amino-terminal domain of the glucocorticoid receptor: no association with puerperal psychosis or schizophrenia. Am. J. Med. Genet. 96: 412-417.
63. Van Rossum, E.F. et al. 2006. Polymorphisms of the glucocorticoid receptor gene and major depression. Biol. Psychiatry 59: 681-688.
64. Krishnamurthy, P. et al. 2008. P.O.W.E.R. (Premenopausal, Osteoporosis Women, Alendronate, Depression) Study Group. Glucocorticoid receptor gene polymorphisms in premenopausal women with major depression. Horm. Metab. Res. 40: 194-198.
65. Zobel, A. et al. 2008. Unipolar depression and hippocampal volume: impact of DNA sequence variants of the glucocorticoid receptor gene. Am. J.Med. Genet. B Neuropsychiatr. Genet. 147B(6): 836-843.
66. Wellcome Trust Case Control Consortium. 2007. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
67. Baum, A.E. et al. 2008. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol. Psychiatry 13: 197-207.
68. Sklar, P. et al. 2008. Whole-genome association study of bipolar disorder. Mol. Psychiatry 13: 558-569.
69. Caspi, A. et al. 2003. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301: 386-389.
70. Meaney, M.J. & M. Szyf. 2005. Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dialogues Clin. Neurosci. 7: 103-123.